brd4 targeting protac 141 (Genentech inc)
90
Structured Review
Genentech inc
brd4 targeting protac 141
Brd4 Targeting Protac 141, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+targeting+protac+141/brd4+targeting+protac+139/pm39834300-226-15-4
Average 90 stars, based on 1 article reviews
Brd4 Targeting Protac 141, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brd4+targeting+protac+141/brd4+targeting+protac+139/pm39834300-226-15-4
Average 90 stars, based on 1 article reviews
brd4 targeting protac 141 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present). Article Snippet: Introduction: The von Hippel-Lindau (VHL) E3 ubiquitin ligase has seen extensive research due to its involvement in the ubiquitin proteasome system and role as a tumor suppressor within the hypoxia signaling pathway.. VHL has become an attractive target for proteolysis targeting chimeras (PROTACs), bifunctional molecules that can induce degradation of neo-substrate proteins.. The development of VHL inhibitors and PROTACs has seen rapid development since disclosure of the first non-peptidic VHL ligand (2012). |